Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda

There is an urgent need for better immunoassays to measure antibody responses as part of immune-surveillance activities and to profile immunological responses to emerging SARS-CoV-2 variants. We optimised and validated an in-house conventional ELISA to identify and quantify SARS-CoV-2 spike- (S-), r...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Gerald Kevin Oluka, Patricia Namubiru, Laban Kato, Violet Ankunda, Ben Gombe, Matthew Cotten, The COVID-19 Immunoprofiling Team, Monica Musenero, Pontiano Kaleebu, Julie Fox, Jennifer Serwanga, Claire Baine, Jackson Sembera, Susan Mugaba, Christine Hermilia Akoli, Geoffrey Odoch, Deus Mwesigwa, Peter Ejou, Joseph Ssebwana Katende
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2023-03-01
Seria:	Frontiers in Immunology
Hasła przedmiotowe:	SARS-CoV-2 spike-protein Nucleoprotein RBD ELISA validation and optimization antibody seropositivity cut-offs
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1113194/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!